rs759347694
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001099922.3(ALG13):āc.3145A>Gā(p.Asn1049Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,203,325 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001099922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG13 | NM_001099922.3 | c.3145A>G | p.Asn1049Asp | missense_variant | 26/27 | ENST00000394780.8 | NP_001093392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG13 | ENST00000394780.8 | c.3145A>G | p.Asn1049Asp | missense_variant | 26/27 | 2 | NM_001099922.3 | ENSP00000378260 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111431Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33613
GnomAD3 exomes AF: 0.0000236 AC: 4AN: 169475Hom.: 0 AF XY: 0.0000343 AC XY: 2AN XY: 58339
GnomAD4 exome AF: 0.0000119 AC: 13AN: 1091894Hom.: 0 Cov.: 30 AF XY: 0.0000279 AC XY: 10AN XY: 357988
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111431Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33613
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 36 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 13, 2021 | This sequence change replaces asparagine with aspartic acid at codon 1049 of the ALG13 protein (p.Asn1049Asp). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and aspartic acid. This variant is present in population databases (rs759347694, ExAC 0.01%). This missense change has been observed in individual(s) with clinical features of ALG13-related disease (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at